ArticleFrontiers in medical technology2022

Enabling Allogeneic T Cell-Based Therapies: Scalable Stirred-Tank Bioreactor Mediated Manufacturing.

Himavanth Gatla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.